EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer
Authors
Keywords
Ovarian cancer, Kidneys, Cancer treatment, Small interfering RNAs, Mouse models, MTT assay, Ovaries, Protein expression
Journal
PLoS One
Volume 10, Issue 4, Pages e0125402
Publisher
Public Library of Science (PLoS)
Online
2015-05-01
DOI
10.1371/journal.pone.0125402
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of ovarian cancer beyond chemotherapy: Are we hitting the target?
- (2014) Álvaro Henrique Ingles Garces et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- EGCG Enhances the Efficacy of Cisplatin by Downregulating hsa-miR-98-5p in NSCLC A549 Cells
- (2014) Dong-Hu Zhou et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy
- (2013) Elena Lecumberri et al. CLINICAL NUTRITION
- Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway
- (2013) Sang Hyuk Lee et al. EUROPEAN JOURNAL OF CANCER
- Enhancement of Cisplatin-Mediated Apoptosis in Ovarian Cancer Cells through Potentiating G2/M Arrest and p21 Upregulation by Combinatorial Epigallocatechin Gallate and Sulforaphane
- (2013) Huaping Chen et al. Journal of Oncology
- Targeting Tumor Ubiquitin-Proteasome Pathway with Polyphenols for Chemosensitization
- (2012) Min Shen et al. Anti-Cancer Agents in Medicinal Chemistry
- An All-Atom Model of the Structure of Human Copper Transporter 1
- (2012) Igor F. Tsigelny et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Mechanistic Basis for Overcoming Platinum Resistance Using Copper Chelating Agents
- (2012) Z. D. Liang et al. MOLECULAR CANCER THERAPEUTICS
- Green Tea Polyphenols as Proteasome Inhibitors: Implication in Chemoprevention
- (2011) H. Yang et al. CURRENT CANCER DRUG TARGETS
- Evaluation of renal protective effects of the green-tea (EGCG) and red grape resveratrol: role of oxidative stress and inflammatory cytokines
- (2011) A.M. El-Mowafy et al. NATURAL PRODUCT RESEARCH
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions
- (2010) Giuliano Ciarimboli et al. AMERICAN JOURNAL OF PATHOLOGY
- Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator
- (2010) Seiko Ishida et al. CANCER CELL
- Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats
- (2010) Kazim Sahin et al. LIFE SCIENCES
- Regulation of Copper Transporter 2 Expression by Copper and Cisplatin in Human Ovarian Carcinoma Cells
- (2010) B. G. Blair et al. MOLECULAR PHARMACOLOGY
- Copper Transporter 2 Regulates Endocytosis and Controls Tumor Growth and Sensitivity to Cisplatin In Vivo
- (2010) B. G. Blair et al. MOLECULAR PHARMACOLOGY
- Novel chemotherapeutic and renal protective effects for the green tea (EGCG): Role of oxidative stress and inflammatory-cytokine signaling
- (2010) A.M. El-Mowafy et al. PHYTOMEDICINE
- Copper Transporter 2 Regulates the Cellular Accumulation and Cytotoxicity of Cisplatin and Carboplatin
- (2009) B. G. Blair et al. CLINICAL CANCER RESEARCH
- Enhanced Delivery of Cisplatin to Intraperitoneal Ovarian Carcinomas Mediated by the Effects of Bortezomib on the Human Copper Transporter 1
- (2009) D. D. Jandial et al. CLINICAL CANCER RESEARCH
- Copper-dependent Recycling of hCTR1, the Human High Affinity Copper Transporter
- (2009) Shannon A. Molloy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oxaliplatin activity in selected and unselected human ovarian and colorectal cancer cell lines
- (2008) Paul Noordhuis et al. BIOCHEMICAL PHARMACOLOGY
- Effects of the loss of Atox1 on the cellular pharmacology of cisplatin
- (2008) Roohangiz Safaei et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- The sensitization of glioma cells to cisplatin and tamoxifen by the use of catechin
- (2008) Amal Shervington et al. MOLECULAR BIOLOGY REPORTS
- The Role of the Mammalian Copper Transporter 1 in the Cellular Accumulation of Platinum-Based Drugs
- (2008) C. A. Larson et al. MOLECULAR PHARMACOLOGY
- Transcription Factor Sp1 Plays an Important Role in the Regulation of Copper Homeostasis in Mammalian Cells
- (2008) I.-S. Song et al. MOLECULAR PHARMACOLOGY
- The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy
- (2007) Matthew D. Hall et al. Annual Review of Pharmacology and Toxicology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More